Paper4053271
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma.
Gilchrist NL and 7 others. Cancer Chemother Pharmacol, 1985. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma. Papers, record 4053271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4053271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma | Major topic |
| Methotrexate | Major topic |
| Adult | |
| Creatinine | |
| Female | |
| Humans | |
| Kinetics | |
| Male | |
| Middle Aged |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6610829 | Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6610829 | PubMed |
| 2 | 832268 | The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion. | Cancer Res | 1977 | https://conductscience.org/library/papers/832268 | PubMed |
| 3 | 6600902 | Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. | Ann Intern Med | 1983 | https://conductscience.org/library/papers/6600902 | PubMed |
| 4 | 267510 | High-dose methotrexate in acute lymphocytic leukemia. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/267510 | PubMed |
| 5 | 7011005 | Intrathecal methotrexate-induced neurotoxicities. | Am J Hosp Pharm | 1981 | https://conductscience.org/library/papers/7011005 | PubMed |
| 6 | 6600662 | Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion. | Clin Pharmacol Ther | 1983 | https://conductscience.org/library/papers/6600662 | PubMed |
| 7 | 806016 | Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. | N Engl J Med | 1975 | https://conductscience.org/library/papers/806016 | PubMed |
| 8 | 433950 | Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy. | Am J Med | 1979 | https://conductscience.org/library/papers/433950 | PubMed |
| 9 | 5630481 | Pharmacology of methotrexate in the human central nervous system. | Surg Gynecol Obstet | 1967 | https://conductscience.org/library/papers/5630481 | PubMed |
| 10 | 7388786 | Active transport of methotrexate from cerebrospinal fluid in humans. | Cancer Res | 1980 | https://conductscience.org/library/papers/7388786 | PubMed |
| 11 | 6141424 | Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. | Lancet | 1984 | https://conductscience.org/library/papers/6141424 | PubMed |
| 12 | 6782926 | Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/6782926 | PubMed |
| 13 | 6344932 | Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients. | Blood | 1983 | https://conductscience.org/library/papers/6344932 | PubMed |
| 14 | 7370167 | Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7370167 | PubMed |
| 15 | 510081 | The development of resistance to methotrexate in a mouse melanoma cell line. I. Characterisation of the dihydrofolate reductases and chromosomes in sensitive and resistant cells. | Chromosoma | 1979 | https://conductscience.org/library/papers/510081 | PubMed |
| 16 | 13973811 | Subarachnoid distribution of drugs after lumbar injection. | N Engl J Med | 1962 | https://conductscience.org/library/papers/13973811 | PubMed |
| 17 | 6353235 | The pharmacology and clinical use of methotrexate. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6353235 | PubMed |
| 18 | 5259150 | Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates. | J Clin Invest | 1969 | https://conductscience.org/library/papers/5259150 | PubMed |
| 19 | 6147703 | Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated? | Lancet | 1984 | https://conductscience.org/library/papers/6147703 | PubMed |
| 20 | 4719662 | Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. | J Clin Invest | 1973 | https://conductscience.org/library/papers/4719662 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20737501 | Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate. | Head Neck | 2012 | https://conductscience.org/library/papers/20737501 | PubMed |
| 16928151 | Pharmacokinetic considerations in the treatment of CNS tumours. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16928151 | PubMed |
| 9696379 | Current diagnosis and treatment of leptomeningeal metastasis. | J Neurooncol | 1998 | https://conductscience.org/library/papers/9696379 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4053271
GET https://conductscience.org/api/papers/v1/4053271/authors